BRIEF: Ping An Health’s profit jumps
Healthcare platform Ping An Healthcare and Technology Co. Ltd. (1833.HK) said on Thursday its profit jumped 72% year-on-year to 184 million yuan ($26 million) in the first nine months of…
BRIEF: Haixi Pharma delays IPO trading debut
Fujian Haixi Pharmaceuticals Co. Ltd. (2637.HK) said on Thursday night that the trading debut for its Hong Kong IPO, originally scheduled for Friday, will be postponed. It blamed the delay…
BRIEF: ImmuneOnco to raise $45 million via share placement at 13% discount
Innovative drug developer ImmuneOnco (1541.HK) announced on Thursday that it plans to place 24.2 million new shares, representing about 5.61% of its enlarged share capital, to raise HK$351 million ($45…
BRIEF: MedBot reports strong year-to-date sales as commercialization accelerates
Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) said on Wednesday that cumulative orders for its core products, including laparoscopic, orthopedic, and vascular intervention surgical robots, surpassed 170 units as of…
BRIEF: Heavily oversubscribed CF PharmTech triples in Hong Kong trading debut
Shares of pharmaceutical manufacturer CF PharmTech Inc. (2652.HK) roared out of the gate in their Hong Kong trading debut on Wednesday, opening up 219% before giving back some of the…
BRIEF: Xuanzhu Biopharma launches IPO to raise $100 million
Xuanzhu Biopharmaceutical Co., Ltd. (2575.HK), spun off from Sihuan Pharma (0460.HK), launched its IPO on Monday, aiming to sell 67.3 million shares for HK$11.60 each to raise HK$780 million ($100…
BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…
Recent Articles
RELATED ARTICLES
-
Lufax deepens Ping An reliance, as it works towards trading resumption
6623.HK LU.US - PomDoc offers up well-conceived but overvalued digital healthcare IPO
-
Years of losses, thin profit margins leave 160 Health feeling down
2656.HK
-
PomDoctor completes U.S. listing ahead of looming Nasdaq crackdown
POM.US
- If you don’t succeed at first, second or third? FWD takes a fourth try at Hong Kong IPO
-
BGM transformed by rapid series of AI acquisitions
BGM.US
-
From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days？
0926.HK
